This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: Annamalai Selvakumar: Innovator in Immunotherapy
Introduction
Annamalai Selvakumar is a prominent inventor based in Bronx, NY (US). He has made significant contributions to the field of immunotherapy, particularly in the generation of antigen-specific T cells. With a total of 3 patents to his name, Selvakumar is recognized for his innovative approaches to cancer treatment.
Latest Patents
One of Selvakumar's latest patents is titled "Use of the IL-15/IL-15Rα complex in the generation of antigen-specific T cells for adoptive immunotherapy." This invention outlines methods for generating antigen-specific T cells for therapeutic administration to patients with pathogens or cancer. The patent details the use of soluble IL-15/IL-15Rα complexes in cell culture to sensitize T cells to specific antigens. Additionally, it describes the generation of antigen-specific T cells and methods for treating patients using these cells. Another notable patent is "Immunogenic WT-1 peptides and methods of use thereof." This invention provides immunogenic compositions and vaccines aimed at treating and inducing immune responses to WT-1-expressing cancers, utilizing peptides derived from the WT-1 protein.
Career Highlights
Annamalai Selvakumar is affiliated with Memorial Sloan Kettering Cancer Center, where he continues to advance research in immunotherapy. His work focuses on innovative methods to enhance the efficacy of cancer treatments through the manipulation of T cell responses.
Collaborations
Selvakumar has collaborated with notable colleagues in his field, including Richard John O'Reilly and Ekaterina Doubrovina. These partnerships have contributed to the development of groundbreaking therapies and research initiatives.
Conclusion
Annamalai Selvakumar's contributions to immunotherapy through his patents and research at Memorial Sloan Kettering Cancer Center highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cancer treatment and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile